
News|Articles|March 1, 2002
Gleevec (Imatinib mesylate capsules), Novartis
New indication: Oral cancer drug approved to treat rare gastrointestinal tumors
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























